Intensive Care Medicine, 46(1), 57-69. Springer Verlag Guidet, B, de Lange, D W, Boumendil, A, Leaver, S, Watson, X, Boulanger, C, Szczeklik, W, Artigas, A, Morandi, A, Andersen, F, Zafeiridis, T, Jung, C, Moreno, R, Walther, S, Oeyen, S, Schefold, J C, Cecconi, M, Marsh, B, Joannidis, M, Nalapko, Y, Elhadi, M, Fjølner, J, Flaatten, H & for the VIP2 study group 2020, ' The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs : the VIP2 study ', Intensive Care Medicine, vol. 46, no. 1, pp. 57-69 . https://doi.org/10.1007/s00134-019-05853-1 Intensive Care Medicine, 46(1), 57-69. SPRINGER Intensive Care Medicine, 46, 57-69 Intensive Care Medicine, 46, 1, pp. 57-69 Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação instacron:RCAAP Intensive Care Medicine Intensive Care Medicine, 46(1), 57. Springer Verlag
Intensive Care Medicine, 44(9), 1598-1601. Springer Verlag Guidet, B, Flaatten, H, Boumendil, A, Morandi, A, Andersen, F H, Artigas, A, Bertolini, G, Cecconi, M, Christensen, S, Faraldi, L, Fjølner, J, Jung, C, Marsh, B, Moreno, R, Oeyen, S, Öhman, C A, Pinto, B B, Soliman, I W, Szczeklik, W, Valentin, A, Watson, X, Zafeiridis, T, De Lange, D W & VIP1 study group (Nilanjan Dey, member of-) 2018, ' Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit ', Intensive Care Medicine, vol. 44, no. 9, pp. 1598-1601 . https://doi.org/10.1007/s00134-018-5312-8, https://doi.org/10.1007/s00134-018-5196-7
BMJ Open Amrein, Karin; Parekh, Dhruv; Westphal, Sabine; Preiser, Jean-Charles; Berghold, Andrea; Riedl, Regina; Eller, Philipp; Schellongowski, Peter; Thickett, David; Meybohm, Patrick (2019). Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study). BMJ open, 9(11), e031083. BMJ Publishing Group 10.1136/bmjopen-2019-031083 BMJ open, 9 (11